From our partners at Huge Alerts Vyome Signs MoU with Embryyo to Target Global AI-Enabled Medical Device Market Vyome Holdings, Inc. (Nasdaq: HIND) is a Cambridge, MA-based healthcare company building a platform that bridges the US-India innovation corridor. The company’s immediate focus is on leveraging its clinical-stage assets to transform the lives of patients suffering from immuno-inflammatory conditions. By combining groundbreaking science with its unique cross-border positioning, Vyome aims to deliver long-term value to shareholders in a highly cost-efficient manner, while maintaining the highest global standards of quality and safety. Vyome Holdings, Inc. (Nasdaq: HIND) today announced it has signed a Memorandum of Understanding (MoU) with Embryyo Technologies, India’s leading medical device innovation studio, to jointly pursue opportunities in the multi-billion-dollar AI-enabled medical device market. The partnership brings together Vyome’s strong position across the US-India healthcare innovation corridor with Embryyo’s decade of experience in developing breakthrough medical device technologies. “Vyome’s vision is to partner with the smartest Indian talent tackling the biggest healthcare markets across the US-India corridor,” said Krishna Gupta, Chairman of Vyome Holdings. “AI-enabled medical devices represent a large opportunity, and the Embryyo team—helmed by IIT alums—has been working in this sector for a decade. We look forward to identifying key initiatives to partner on.” Embryyo Co-Founder and CEO Nishant Kumar added: “This partnership with Vyome will accelerate our mission to push the frontiers of medicine and elevate standards of care globally. Vyome’s access to global capital markets and the U.S. healthcare ecosystem provides a powerful platform for scaling our portfolio of transformative medical devices spanning interventional oncology, surgery, wearables, and drug delivery.” As part of this collaboration, Vyome and Embryyo plan to host a global AI-enabled medical device innovation forum to bring together stakeholders across the US-India corridor. The MoU is non-binding and subject to customary conditions. | 
0 Response to "Vyome (Nasdaq: HIND) Targets Billion-Dollar Healthcare Market"
Post a Comment